Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine with or without oxycodone for postoperative iliac fascia block analgesia after hip arthroplasty
ChiCTR2300071762Phase 4Not yet recruiting
- Sponsor
- Central Hospital of Enshi Tujia and Miao Autonomous Prefecture
- Start
- Apr 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ropivacaine and oxycodone in postoperative pain (2 arms), sponsored by Central Hospital of Enshi Tujia and Miao Autonomous Prefecture. Primary endpoint: Time to first postoperative remedial analgesia. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
ropivacaineoxycodone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300071762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071762.